Aspen buys GSK brands
Fin24 - Apr 23rd 2012, 14:01
London - GlaxoSmithKline has agreed to sell a clutch of international over-the-counter healthcare brands for Â£164m to South Africaâ€™s Aspen Pharmacare Holdings [JSE:APN], Britainâ€™s biggest drugmaker said on Friday.
Cash proceeds from the transaction are expected to be about Â£135m and will be returned to shareholders during 2012.
The sale is the latest move by GSK to fine-tune its consumer healthcare business and follows the divestment of other over-the-counter brands in North America and Europe.
The brands being sold generated sales of around Â£60m in 2011. They include the painkiller Solpadeine and anti-stomach acid drug Zantac.
The net profit realised on the disposal in 2012 - after deducting transaction costs and a profit deferral of some Â£25m pre-tax because Aspen is a GSK associate - is expected to be Â£105m before tax, or Â£90m after tax.
GSK added it continued to plan to sell its OTC weight-loss pill Alli. This process has been delayed due to supply problems at a Roche factory in the United States.
The Swiss company manufactures the active ingredient, orlistat, which is also the active substance in Rocheâ€™s prescription-only drug Xenical. Alli is a low-dose version of Xenical.
GSK first announced in February 2011 that it planned to dispose of non-core brands sold primarily in North America and Europe and representing about 10% of its consumer health portfolio, in order to focus on priority brands and emerging markets.
Pharmaceuticals: Adcock names new executives
14/06/2013 - 10:19
Pharmaceutical firm Adcock Ingram has appointed Werner van Rensburg as its chief operations officer, and Doreen Kosi has been confirmed as the government relations executive.
India: P&G to set up its biggest India plant in Andhra Pradesh
11/06/2013 - 10:10
FMCG major Procter & Gamble (P&G) India is enhancing its manufacturing capabilities and expanding its footprint by setting up its largest plant at Kothur Mandal in Mahaboobnagar district of Andhra Pradesh. The company will be investing R370 crore in the plant through Procter & Gamble Home Products.
Zimbabwe: New procurement law on cards
30/05/2013 - 10:47
Speaking at the Buy Zimbabwe procurement conference in Harare yesterday, Kasukuwere said companies should comply with the stipulated procurement regulations, in which local firms should be granted at least 50% contracts on procurement deals.
UK retailers suffered sales drop in April, BRC report shows
15/05/2013 - 15:23
Retailers suffered a 2.2% drop in sales last month compared with a year ago, thanks to the timing of Easter and wintry weather, according to industry figures.
Adcock gets proposals for 100% aquisition
10/05/2013 - 08:05
South African drugmaker Adcock Ingram said on Thursday a rival bid was in the offing to a $675m (R60.7) one made by conglomerate Bidvest [JSE:BVT], raising the stakes for a possible acquisition and pushing its share price up almost 8%.